QQQ   316.39 (-1.35%)
AAPL   164.07 (-0.49%)
MSFT   278.63 (-0.60%)
META   167.26 (-1.76%)
GOOGL   116.22 (-0.92%)
AMZN   136.76 (-1.90%)
TSLA   852.59 (-2.14%)
NVDA   171.09 (-3.84%)
NIO   19.42 (-3.72%)
BABA   91.34 (+0.55%)
AMD   96.48 (-3.59%)
MU   58.79 (-4.33%)
T   18.14 (+0.78%)
CGC   3.01 (-8.23%)
GE   75.43 (+0.33%)
F   15.52 (-1.65%)
DIS   107.41 (-1.56%)
AMC   22.71 (-5.22%)
PYPL   94.43 (-1.90%)
PFE   49.83 (+0.52%)
NFLX   225.17 (-3.56%)
QQQ   316.39 (-1.35%)
AAPL   164.07 (-0.49%)
MSFT   278.63 (-0.60%)
META   167.26 (-1.76%)
GOOGL   116.22 (-0.92%)
AMZN   136.76 (-1.90%)
TSLA   852.59 (-2.14%)
NVDA   171.09 (-3.84%)
NIO   19.42 (-3.72%)
BABA   91.34 (+0.55%)
AMD   96.48 (-3.59%)
MU   58.79 (-4.33%)
T   18.14 (+0.78%)
CGC   3.01 (-8.23%)
GE   75.43 (+0.33%)
F   15.52 (-1.65%)
DIS   107.41 (-1.56%)
AMC   22.71 (-5.22%)
PYPL   94.43 (-1.90%)
PFE   49.83 (+0.52%)
NFLX   225.17 (-3.56%)
QQQ   316.39 (-1.35%)
AAPL   164.07 (-0.49%)
MSFT   278.63 (-0.60%)
META   167.26 (-1.76%)
GOOGL   116.22 (-0.92%)
AMZN   136.76 (-1.90%)
TSLA   852.59 (-2.14%)
NVDA   171.09 (-3.84%)
NIO   19.42 (-3.72%)
BABA   91.34 (+0.55%)
AMD   96.48 (-3.59%)
MU   58.79 (-4.33%)
T   18.14 (+0.78%)
CGC   3.01 (-8.23%)
GE   75.43 (+0.33%)
F   15.52 (-1.65%)
DIS   107.41 (-1.56%)
AMC   22.71 (-5.22%)
PYPL   94.43 (-1.90%)
PFE   49.83 (+0.52%)
NFLX   225.17 (-3.56%)
QQQ   316.39 (-1.35%)
AAPL   164.07 (-0.49%)
MSFT   278.63 (-0.60%)
META   167.26 (-1.76%)
GOOGL   116.22 (-0.92%)
AMZN   136.76 (-1.90%)
TSLA   852.59 (-2.14%)
NVDA   171.09 (-3.84%)
NIO   19.42 (-3.72%)
BABA   91.34 (+0.55%)
AMD   96.48 (-3.59%)
MU   58.79 (-4.33%)
T   18.14 (+0.78%)
CGC   3.01 (-8.23%)
GE   75.43 (+0.33%)
F   15.52 (-1.65%)
DIS   107.41 (-1.56%)
AMC   22.71 (-5.22%)
PYPL   94.43 (-1.90%)
PFE   49.83 (+0.52%)
NFLX   225.17 (-3.56%)
NYSEAMERICAN:ARMP

Armata Pharmaceuticals - ARMP Stock Forecast, Price & News

$4.22
+0.11 (+2.67%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.11
$4.25
50-Day Range
N/A
52-Week Range
$2.82
$6.49
Volume
1,369 shs
Average Volume
3,030 shs
Market Capitalization
$152.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ARMP stock logo

About Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Stock

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

Receive ARMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARMP Stock News Headlines

See More Headlines
Receive ARMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ARMP Company Calendar

Last Earnings
5/12/2022
Today
8/09/2022
Next Earnings (Estimated)
8/10/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:ARMP
CIK
N/A
Employees
69
Year Founded
N/A

Profitability

Net Income
$-23,160,000.00
Net Margins
-569.21%
Pretax Margin
-569.21%

Debt

Sales & Book Value

Annual Sales
$4.47 million
Book Value
$0.94 per share

Miscellaneous

Free Float
8,053,000
Market Cap
$152.56 million
Optionable
Not Optionable
Beta
1.02

Key Executives

  • Dr. Brian Varnum Ph.D. (Age 62)
    CEO & Director
    Comp: $695.53k
  • Mr. Steven R. Martin (Age 61)
    Advisor
    Comp: $519.12k
  • Mr. Todd R. Patrick MBA (Age 59)
    Advisor & Director
    Comp: $1.25M
  • Dr. Wenyuan Shi Ph.D.
    Co-Founder & Founding Scientist
  • Ms. Erin Butler
    Principal Financial & Accounting Officer and VP of Fin. & Admin.
  • Mr. Duane Alfred Morris BA (Age 72)
    VP of Operations
  • Dr. Mina Pastagia M.D.
    MS, Sr. VP of Clinical Devel.













ARMP Stock - Frequently Asked Questions

How has Armata Pharmaceuticals' stock price performed in 2022?

Armata Pharmaceuticals' stock was trading at $4.87 at the start of the year. Since then, ARMP stock has decreased by 13.2% and is now trading at $4.2250.
View the best growth stocks for 2022 here
.

Are investors shorting Armata Pharmaceuticals?

Armata Pharmaceuticals saw a decrease in short interest in June. As of June 30th, there was short interest totaling 73,600 shares, a decrease of 20.6% from the June 15th total of 92,700 shares. Based on an average daily volume of 6,100 shares, the days-to-cover ratio is currently 12.1 days. Currently, 0.7% of the shares of the stock are short sold.
View Armata Pharmaceuticals' Short Interest
.

When is Armata Pharmaceuticals' next earnings date?

Armata Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our ARMP earnings forecast
.

How were Armata Pharmaceuticals' earnings last quarter?

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) released its quarterly earnings results on Thursday, May, 12th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.20) by $0.10. The company earned $1.24 million during the quarter, compared to analyst estimates of $0.95 million. Armata Pharmaceuticals had a negative trailing twelve-month return on equity of 75.90% and a negative net margin of 569.21%.

What other stocks do shareholders of Armata Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Armata Pharmaceuticals investors own include VBI Vaccines (VBIV), Vaxart (VXRT), Amarin (AMRN), CRISPR Therapeutics (CRSP), Pfizer (PFE), Micron Technology (MU), Aduro Biotech (ADRO), Occidental Petroleum (OXY) and Gilead Sciences (GILD).

What is Armata Pharmaceuticals' stock symbol?

Armata Pharmaceuticals trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ARMP."

How do I buy shares of Armata Pharmaceuticals?

Shares of ARMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Armata Pharmaceuticals' stock price today?

One share of ARMP stock can currently be purchased for approximately $4.23.

How much money does Armata Pharmaceuticals make?

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a market capitalization of $152.57 million and generates $4.47 million in revenue each year. The company earns $-23,160,000.00 in net income (profit) each year or ($1.00) on an earnings per share basis.

How many employees does Armata Pharmaceuticals have?

Armata Pharmaceuticals employs 69 workers across the globe.

How can I contact Armata Pharmaceuticals?

Armata Pharmaceuticals' mailing address is 4503 GLENCOE AVENUE, MARINA DEL REY CA, 90292. The official website for the company is www.armatapharma.com. The company can be reached via phone at (310) 655-2928, via email at jallaire@lifesciadvisors.com, or via fax at 310-665-2963.

This page (NYSEAMERICAN:ARMP) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.